Screen Reader Mode Icon

Question Title

* 1. Name & Role

Question Title

* 2. Investigator Site

Question Title

* 3. Email address

Question Title

* 4. Would you be interested in taking part in the TNT-OAC trial?

Question Title

* 5. What perioperative oncological therapy do you routinely offer patients with oesophageal or junctional (Siewert I & II) adenocarcinoma?

Question Title

* 6. Approximately how many patients are there discussed at your MDT with operable disease per annum?

Question Title

* 7. Of those, how many do you think will be eligible for screening for the trial per annum?

Question Title

* 8. Do you see any issues with obtaining translational samples as detailed (in email/synopsis)?

Question Title

* 9. Do you have any questions or comments about the trial design?

T